Findings compared with U.S. adult trauma patients with private or Medicaid insurance
FRIDAY, Aug. 2, 2024 (HealthDay News) — Early withdrawal of life-sustaining therapy (WLST) is more likely among uninsured trauma patients, according to a study published online July 24 in JAMA Network Open.
Graeme Hoit, M.D., from the University of Toronto, and colleagues assessed if patient insurance type (private insurance, Medicaid, and uninsured) is associated with time to WLST in critically injured adults treated at U.S. trauma centers. The analysis included 307,731 patients injured between Jan. 1, 2017, and Dec. 31, 2020.
The researchers found that 4.2 percent of patients underwent WLST during their admission. Earlier WLST was significantly more likely among patients who were uninsured versus those with private insurance (hazard ratio, 1.54) and Medicaid (hazard ratio, 1.47). When excluding patients who died within 48 hours of presentation and after accounting for nonwithdrawal death as a competing risk, findings persisted.
“In this cohort study of U.S. adult trauma patients who were critically injured, patients who were uninsured underwent earlier WLST compared with those with private or Medicaid insurance,” the authors write. “Based on our findings, a patient’s ability to pay was likely associated with a shift in decision-making for WLST, suggesting that socioeconomic status affects patient outcomes.”
One author disclosed ties to the medical technology industry.
Mortality in Injured Children Linked to Higher SBP Thresholds Than Those That Define Hypotension
ED Visits for Gambling Disorder Spike After Canada Liberalizes Online Gambling
Nearly 2 in 3 Poison Exposures in Young Children May Not Need the ED
Lower Breast, Cervical Cancer Screening Seen for Adults With Disabilities
Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years
Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis
Family History of CRC Increases CRC Risk Similarly in IBD, General Population
H. Pylori Exposure May Contribute to Global Burden of Colorectal Cancer